Form 4: Daxor Corp Insider Acquires Shares

Daxor Corp. Chief Scientific Officer Jonathan Feldschuh acquired 25,000 shares of common stock.

Summary

• Jonathan Adam Feldschuh, Chief Scientific Officer and Director of Daxor Corp. (DXR), acquired 25,000 shares of common stock on June 23, 2026.
• The acquisition was made at a price of $0, indicating a grant or award.
• These shares are scheduled to vest on June 23, 2026.
• Following this transaction, Feldschuh beneficially owns 78,908 shares of Daxor Corp. common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents an insider stock grant which is typical for executive compensation, rather than a market purchase indicating strong conviction.

Positives

• Insider acquisition of shares by a key executive (Chief Scientific Officer and Director) can signal confidence in the company's future prospects.
• The acquisition of 25,000 shares indicates a significant stake being granted to a key executive.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. The only future-oriented information pertains to the vesting date of the acquired shares.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by C-suite executives and directors, are often viewed positively by the market as they align executive interests with shareholder value. However, the nature of this transaction as a grant with a future vesting date suggests it is part of executive compensation rather than an open market purchase.

Stakeholder Impact

• Shareholders: The acquisition by a key executive may be interpreted as a positive signal of management's commitment and belief in the company's future, potentially influencing investor sentiment.
• Employees: As part of executive compensation, this transaction highlights the company's strategy for incentivizing its leadership.
• Management: The transaction directly impacts the beneficial ownership of Jonathan Feldschuh, aligning his financial interests with the company's performance.

Next Steps

• The 25,000 shares granted will vest on June 23, 2026.

Key Dates

Keywords

Daxor Corp, DXR, Insider Trading, Form 4, Stock Acquisition, Executive Compensation, Beneficial Ownership